Transmembrane helix interactions regulate oligomerization of the receptor tyrosine kinase EphA2

被引:0
|
作者
Wirth, Daniel [1 ]
Ozdemir, Ece [1 ]
Wimley, William C. [2 ]
Pasquale, Elena B. [3 ]
Hristova, Kalina [1 ]
机构
[1] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
[2] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA USA
[3] Sanford Burnham Prebys Med Discovery Inst, Canc Metab & Microenvironm Program, La Jolla, CA USA
关键词
FRET SIGNATURES; DOMAIN; DIMERIZATION; ACTIVATION; MUTATIONS; MECHANISM; DISCOVERY; PROTEINS; PEPTIDE; EPHRINS;
D O I
10.1016/j.jbc.2024.107441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transmembrane helices of receptor tyrosine kinases (RTKs) have been proposed to switch between two different dimeric conformations, one associated with the inactive RTK and the other with the active RTK. Furthermore, recent work has demonstrated that some full-length RTKs are associated into oligomers that are larger than dimers, raising questions about the roles of the TM helices in the assembly and function of these oligomers. Here we probe the roles of the TM helices in the assembly of EphA2 RTK oligomers in the plasma membrane. We employ mutagenesis to evaluate the relevance of a published NMR dimeric structure of the isolated EphA2 TM helix in the context of the full-length EphA2 in the plasma membrane. We use two fluorescence methods, F & ouml;rster Resonance Energy Transfer and Fluorescence Intensity Fluctuations spectrometry, which yield complementary information about the EphA2 oligomerization process. These studies reveal that the TM helix mutations affect the stability, structure, and size of EphA2 oligomers. However, the effects are multifaceted and point to a more complex role of the TM helix than the one expected from the "TM dimer switch" model.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Mutations of the EPHA2 Receptor Tyrosine Kinase Gene Cause Autosomal Dominant Congenital Cataract
    Zhang, Tianxiao
    Hua, Rui
    Xiao, Wei
    Burdon, Kathryn P.
    Bhattacharya, Shomi S.
    Craig, Jamie E.
    Shang, Dandan
    Zhao, Xiuli
    Mackey, David A.
    Moore, Anthony T.
    Luo, Yang
    Zhang, Jinsong
    Zhang, Xue
    HUMAN MUTATION, 2009, 30 (05) : E603 - E610
  • [32] 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors
    Lim, Chae Jo
    Oh, Kwang-Seok
    Du Ha, Jae
    Lee, Jeong Hyun
    Seo, Ho Won
    Chae, Chong Hack
    Kim, Dae-Ghon
    Lee, Mi-Jin
    Lee, Byung Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4080 - 4083
  • [33] Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
    Chang, Q.
    Jorgensen, C.
    Pawson, T.
    Hedley, D. W.
    BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1074 - 1082
  • [34] Expression, purification, and initial characterization of the cytoplasmic domains of the human receptor tyrosine kinase, EphA2
    Zabell, KM
    Kinch, MS
    Knapp, DW
    Stauffacher, CV
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 254A - 254A
  • [35] Receptor Tyrosine Kinase EPHA2 Drives Epidermal Differentiation through Regulation of EGFR Signaling
    White, Bethany E. Perez
    Cable, Calvin J.
    Shi, Bo
    Ventrella, Rosa
    Kaplan, Nihal
    Kobeissi, Aya
    Higuchi, Yuya
    Balu, Abhinav
    Murphy, Zachary R.
    Kumar, Priya
    Getsios, Spiro
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08)
  • [36] Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
    Q Chang
    C Jorgensen
    T Pawson
    D W Hedley
    British Journal of Cancer, 2008, 99 : 1074 - 1082
  • [37] Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin
    Guo, Hong
    Miao, Hui
    Gerber, Lizabeth
    Singh, Jarnail
    Denning, Mitchell F.
    Gilliam, Anita C.
    Wang, Bingcheng
    CANCER RESEARCH, 2006, 66 (14) : 7050 - 7058
  • [38] High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia
    Zeng, GY
    Hu, ZQ
    Kinch, MS
    Pan, CX
    Flockhart, DA
    Kao, CH
    Gardner, TA
    Zhang, SB
    Li, L
    Baldridge, LA
    Koch, MO
    Ulbright, TM
    Eble, JN
    Cheng, L
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06): : 2271 - 2276
  • [39] A Novel Membrane Peptide that Inhibits Cell Migration by Activation of the Receptor Tyrosine Kinase EphA2
    Westerfield, Justin M.
    Alves, Daiane S.
    Shi, Xiaojun
    Nguyen, Vanessa P.
    Pullen, Robert H., III
    Stefanski, Katherine M.
    Booth, Kristen
    Morrell-Falvey, Jennifer
    Wang, Bing-Cheng
    Abel, Steven M.
    Smith, Adam W.
    Barrera, Francisco N.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 265A - 265A
  • [40] SAM Domain Inhibits Oligomerization and Auto-Activation of EphA2 Kinase
    Shi, Xiaojun
    Bowman, Deanna M.
    Hapiak, Vera M.
    Lingerak, Ryan W.
    Zheng, Ji
    Buck, Matthias
    Wang, Bingcheng
    Smith, Adam W.
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 27A - 27A